NCT04875026 - Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial | Biotech Hunter

Enrollment

146

Participants

Timeline

Start Date

February 16, 2021

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions

Actinic Keratoses

Interventions

DRUG

5-fluorouracil 4% (Tolak)

Application of Tolak once daily in the evening for 4 weeks

DEVICE

Dexeryl

Application of Dexeryl once daily in the morning for 8 weeks

Trial Locations (27)

58453

Hautarztpraxis, Witten

Unknown

Private practice Maire, Arras

Chu de Nantes Hôtel-Dieu, Nantes

CHU Pau, Pau

CHU Poitiers, Poitiers

CHU St Etienne Hopital Nord, Saint-Etienne

Kath. Klinikum Bochum St. Josef-Hospital, Bochum

MVZ Dermatologisches Zentrum Bonn GmbH, Bonn

Private practice Quist, Bretzenheim

Private Practice Kurzen, Freising

Dermatologikum Hamburg, Hamburg

CentroDerm Clinic, Witten

Uni Clinic Brescia, Brescia

Uni Clinic Catania, Catania

Uni Clinic L'Aquila, Coppito

Policlinico San Martino, Genova

University of Messina, Messina

Uni Clinic Modena, Modena

NAPLES VANVITELLI UNIVERSITI (Federico II Hospital), Napoli

Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia

Catholic University Fondazione Policlinico Universitario A. Gemelli, Roma

Sapienza University of Rome - Polo Pontino, Terracina

Centre medic Congres, Barcelona

Hospital Alfredo Espinosa, Bilbao

Hospital Universitario Infanta Leonor, Madrid

Instituto Valenciano de Oncología,, Valencia

Hospital Marina Baixa, Villajoyosa